Sterigenics announced plans today to expand a medical device sterilization plant in Rantigny, France.
The expansion of the ethylene oxide (EtO) plant will enable the addition of a 32-pallet sterilization chamber.
“Local and regional demand for contract sterilization services has been increasing to meet healthcare needs,” said Pontus Rundstrom, VP of operations for Sterigenics in Europe, the Middle East and Africa, in a news release. “The additional capacity at Rantigny shows our commitment to our sterilization customers by helping to get their products into the market in a fast, flexible and reliable way.”
The Sterigenics’ Rantigny facility provides routine and rapid EtO processing, cycle development and process validation, and offers laboratory testing services through its co-located Nelson Labs facility. The Rantigny expansion follows Sterigenics’ August 2020 acquisition of Iotron Industries, a Canada-based electron beam (EBeam) sterilization provider in North America.
